Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 3
Submit an article Journal homepage
303
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor

Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab

Robert C. QuackenbushSt. Mary Medical Center, Walla Walla, WA, USA
,
Thierry J. HornerGlaxoSmithKline, Collegeville, PA, USA
,
Vanessa C. WilliamsGlaxoSmithKline, Research Triangle Park, NC, USA
,
Patricia GiampietroGlaxoSmithKline, Collegeville, PA, USA
&
Thomas S. LinGlaxoSmithKline, Collegeville, PA, USACorrespondence[email protected]
Pages 779-781 | Received 24 Feb 2014, Accepted 18 May 2014, Published online: 23 Jul 2014

References

  • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
  • Morschhauser F, Radford J, Van Hoof A, et al. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol 2008;26:5156–5164.
  • Press OW, Unger JM, Rimsza LM, et al. A Phase III randomized intergroup trial (SWOG S0016) of CHOP chemotherapy plus rituximab vs. CHOP chemotherapy plus iodine-131-tositumomab for the treatment of newly diagnosed follicular non-Hodgkin's lymphoma. Blood 2011;118(Suppl. 1): Abstract 98.
  • Wahl RL. Tositumomab and (131)I therapy in non-Hodgkin's lymphoma. J Nucl Med 2005;46(Suppl. 1):128S–140S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.